Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Medical University of Innsbruck, Innsbruck, Austria
Medical University of Vienna, Vienna, Austria
Nitin Sethi, New Delhi, Delhi, India
Sir Run Run Hospital, Nanjing, Jiangsu, China
London Health Sciences Centre, London, Ontario, Canada
Menoufia University, Shibīn Al Kawm, Menoufia, Egypt
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan
Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing, China
The Second Affiliated Hospital of Zhejiang University anesthesiology department, Hangzhou, Zhejiang, China
Kasralaini Medical School, Cairo, Egypt
Wuhan Union Hospital, Wuhan, Hubei, China
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.